SLNO
Soleno Therapeutics·NASDAQ
--
--(--)
--
--(--)
0.80 / 10
Underperform
SLNO's fundamental score is 0.8/10, reflecting poor quality. Key negative factors include Net profit margin (-22.77%), EBIT/Revenue (-30.57%), and Net cash flow/Revenue (-1.93%). Asset-MV (-0.5007) and Revenue-MV (-1.7219) are unfavorable, and their historical returns are negative. Although revenue grew 78.47% YoY, group 4 historical return is -6.59%. Current assets turnover (0.2381) is low. Together, these indicate weak fundamentals and limited upside.
Analysis Checks(1/10)
Revenue-MV
Value-1.72
Score0/3
Weight9.21%
1M Return-2.92%
Value-1.72
Score0/3
Weight9.21%
1M Return-2.92%
Total operating revenue (YoY growth rate %)
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Net income-Revenue
Value0.86
Score1/3
Weight1.90%
1M Return-0.69%
Value0.86
Score1/3
Weight1.90%
1M Return-0.69%
Current assets turnover ratio
Value0.24
Score1/3
Weight4.63%
1M Return-1.72%
Value0.24
Score1/3
Weight4.63%
1M Return-1.72%
Asset-MV
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Net cash flow from operating activities / Operating revenue (%)
Value-1.93
Score0/3
Weight15.95%
1M Return-7.70%
Value-1.93
Score0/3
Weight15.95%
1M Return-7.70%
Net profit margin (%)
Value-22.77
Score0/3
Weight16.62%
1M Return-8.03%
Value-22.77
Score0/3
Weight16.62%
1M Return-8.03%
EBIT / Total operating revenue (%)
Value-30.57
Score0/3
Weight15.72%
1M Return-7.44%
Value-30.57
Score0/3
Weight15.72%
1M Return-7.44%
Net profit / Total operating revenue (%)
Value-22.77
Score0/3
Weight16.30%
1M Return-7.85%
Value-22.77
Score0/3
Weight16.30%
1M Return-7.85%
Revenue-MV
Value-1.72
Score0/3
Weight9.21%
1M Return-2.92%
Value-1.72
Score0/3
Weight9.21%
1M Return-2.92%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Value100.00
Score2/3
Weight4.26%
1M Return-1.63%
Total operating revenue (YoY growth rate %)
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Value78.47
Score0/3
Weight13.82%
1M Return-6.59%
Net cash flow from operating activities / Operating revenue (%)
Value-1.93
Score0/3
Weight15.95%
1M Return-7.70%
Value-1.93
Score0/3
Weight15.95%
1M Return-7.70%
Net income-Revenue
Value0.86
Score1/3
Weight1.90%
1M Return-0.69%
Value0.86
Score1/3
Weight1.90%
1M Return-0.69%
Net profit margin (%)
Value-22.77
Score0/3
Weight16.62%
1M Return-8.03%
Value-22.77
Score0/3
Weight16.62%
1M Return-8.03%
Current assets turnover ratio
Value0.24
Score1/3
Weight4.63%
1M Return-1.72%
Value0.24
Score1/3
Weight4.63%
1M Return-1.72%
EBIT / Total operating revenue (%)
Value-30.57
Score0/3
Weight15.72%
1M Return-7.44%
Value-30.57
Score0/3
Weight15.72%
1M Return-7.44%
Asset-MV
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Value-0.50
Score1/3
Weight1.58%
1M Return-0.51%
Net profit / Total operating revenue (%)
Value-22.77
Score0/3
Weight16.30%
1M Return-7.85%
Value-22.77
Score0/3
Weight16.30%
1M Return-7.85%
Is SLNO fundamentally strong?
- SLNO scores 0.80/10 on fundamentals and holds a Premium valuation at present. Backed by its -6.07% ROE, 0.00% net margin, -12.32 P/E ratio, 4.51 P/B ratio, and 37.28% earnings growth, these metrics solidify its Underperform investment rating.
